Question 1

What is the Tesamorelin/Ipamorelin combination?

Accepted Answer

This combination pairs Tesamorelin (a GHRH analog) with Ipamorelin (a GHS-R1a agonist) for multi-pathway signaling research in controlled laboratory settings.

Question 2

Why study these peptides together?

Accepted Answer

Researchers examine this combination to investigate coordinated activation of GHRH and ghrelin receptor pathways in preclinical models.

Question 3

How is product quality verified?

Accepted Answer

Every batch undergoes 7 rounds of independent analytical testing including HPLC purity analysis, mass spectrometry identity confirmation, endotoxin screening, and sterility verification. Full Certificates of Analysis documenting all results are available for each production lot.

Question 4

Can this compound be studied alongside other research peptides?

Accepted Answer

In controlled laboratory settings, researchers may evaluate this compound in combination with other peptides to examine complementary or overlapping signaling pathways within established research protocols.

SKU	IP-TESA-13/IPA
Intended Use	For laboratory research use only. Not for human consumption.

Tesamorelin 13mg / Ipamorelin 3mg